HomeInsightsStock Comparison

Megasoft Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Megasoft Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: May 12, 2025

Key Highlights

  • The Latest Trading Price of Megasoft Ltd is ₹ 66.53 as of 12 May 10:19.
  • The P/E Ratio of Megasoft Ltd changed from 31.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Megasoft Ltd changed from ₹ 22.27 crore on March 2020 to ₹ 659.06 crore on March 2024 . This represents a CAGR of 96.90% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Megasoft Ltd for the Dec '24 is ₹ 12.73 crore as compare to the Sep '24 revenue of ₹ 8.56 crore. This represent the growth of 48.71% The revenue of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 14141 crore as compare to the Sep '24 revenue of ₹ 13645 crore. This represent the growth of 3.63%.
  • The ebitda of Megasoft Ltd for the Dec '24 is ₹ 9.4 crore as compare to the Sep '24 ebitda of ₹ 6.43 crore. This represent the growth of 46.19% The ebitda of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 4158 crore as compare to the Sep '24 ebitda of ₹ 4292 crore. This represent the decline of -3.13%.
  • The net profit of Megasoft Ltd changed from ₹ 3.25 crore to ₹ 3.59 crore over 7 quarters. This represents a CAGR of 5.85% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2917 crore over 7 quarters. This represents a CAGR of 23.62% .
  • The Dividend Payout of Megasoft Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Megasoft Ltd

  • Megasoft Limited is a transnational intellectual property-driven, product-based technology company, which incorporated on 29th June 1999 and focused its expertise on the telecom sector.
  • The Company provides telecom services throughout the globe under XIUS-bcgi and also offers Outsourcing, Off-shoring and back-office services to other product companies in the areas of Product Life Cycle Management (PLM) & and Application Development & Maintenance Services (ADMS) under the name and style of BlueAlly.
  • Megasoft has strong product engineering and product development capacities with Capability Maturity Model (CMM) Level 5 certification and has operations in India, U.S., UK, Singapore, Malaysia and Germany. The Company had merged with Indus e solutions a public listed company in the year of 2000.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Megasoft Ltd News Hub

News

Megasoft to hold board meeting

Megasoft will hold a meeting of the Board of Directors of the Company on 14 February 2025....

Read more

11 Feb 2025 11:19

News

Megasoft schedules board meeting

Megasoft will hold a meeting of the Board of Directors of the Company on 11 November 2024 ...

Read more

07 Nov 2024 14:15

News

Megasoft to conduct AGM

Megasoft announced that the Annual General Meeting (AGM) of the company will be held on 27...

Read more

06 Sep 2024 16:38

News

Megasoft schedules AGM

Megasoft announced that the Annual General Meeting (AGM) of the company will be held on 27...

Read more

06 Sep 2024 17:41

News

Megasoft Ltd leads losers in 'B' group

Nucleus Software Exports Ltd, Ola Electric Mobility Ltd, Atam Valves Ltd and Akums Drugs &...

Read more

22 Aug 2024 14:45

News

Megasoft revises board meeting date

Megasoft has revised the meeting of the Board of Directors which was scheduled to be held ...

Read more

08 Aug 2024 11:02

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharmaceutical Industries Ltd Slips 5.32%

Sun Pharmaceutical Industries Ltd fell 5.32% today to trade at Rs 1652.1. The BSE Healthca...

Read more

12 May 2025 09:30

News

Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II

Sun Pharmaceutical Industries and Israel-based Moebius Medical announced today the publica...

Read more

24 Apr 2025 09:12

News

Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India

Sun Pharmaceutical Industries has launched Fexuprazan tablets 40 mg in India under the bra...

Read more

07 Apr 2025 09:07

News

Sun Pharma launches Fexuprazan tablets 40 mg in India

The drug, available in 40 mg tablets, is approved as a new treatment for adults with erosi...

Read more

07 Apr 2025 10:23

News

Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada

Sun Pharmaceutical Industries has completed 100% acquisition of Antibe Therapeutics Inc., ...

Read more

18 Mar 2025 15:01

News

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with a specialty...

Read more

18 Mar 2025 12:53

SWOT Analysis Of Megasoft Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Megasoft Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Megasoft Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Megasoft Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Megasoft Ltd is 467 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 418,647 Cr

What are the key factors driving the stock performance of Megasoft Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Megasoft Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Megasoft Ltd and Sun Pharmaceutical Industries Ltd?

As of May 12, 2025, the Megasoft Ltd stock price is INR ₹63.37. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1744.85.

How do dividend payouts of Megasoft Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Megasoft Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions